Trials / Recruiting
RecruitingNCT05930184
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
Comparison of Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy, A Prospective Randomized Controlled Study
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 98 (estimated)
- Sponsor
- Khon Kaen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized controlled trial is to compare laparoscopic guided peri-wound Transversus Abdominis Plane Block and bupivacaine versus local wound infiltration effect on reducing post-op opioid use in Laparoscopic Sleeve gastrectomy. The main questions it aims to answer are: • Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration. Participants will be randomize into 2 group * peri-wound Transversus Abdominis Plane Block * local wound port site infiltration
Conditions
- Morbid Obesity
- Laparoscopic Sleeve Gastrectomy
- Transversus Abdominis Plane Block
- Local Wound Infiltration
- Bupivacine
- Opioid Use
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | peri-wound Transversus Abdominis Plane Block | 0.25% bupivacaine 20ml was injected using no24 needle into a plane between internal oblique muscle and transversus abdominis muscle around every wound 2 cm. from wound opening. The procedure was confirmed by laparoscopic vision and the injection was done before removal of laparoscopic port. |
| PROCEDURE | Local wound infiltration | 0.25% bupivacaine 20ml was injected using no24 needle into subcutaneous tissue after the abdominal sheet was sutured. |
Timeline
- Start date
- 2023-04-29
- Primary completion
- 2024-01-29
- Completion
- 2024-12-01
- First posted
- 2023-07-05
- Last updated
- 2024-05-01
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05930184. Inclusion in this directory is not an endorsement.